Etiological causes in patients with acute urticaria and angioedema: A cross-sectional study

Main Article Content

Mehmet Melikoglu https://orcid.org/0000-0001-7554-7658
Erdal Pala
Mustafa Bayraktar https://orcid.org/0000-0001-8486-9915

Keywords

Angioedema, allergens, exacerbation, symptom, urticaria, blood tests

Abstract

Background: Acute urticaria and angioedema are emergency dermatological conditions associated with various etiologic factors.


Objective: To determine the etiological causes in patients with acute urticaria and angioedema, and to investigate whether more than one etiological cause was present, along with the patients’ laboratory values.


Methods: The study was conducted in a tertiary hospital with one center. Etiological causes and laboratory parameters in 284 patients diagnosed with acute urticaria and angioedema were retrospectively studied.


Results: A total of 284 patients were included in the study. The mean age of the patients was 42.7 ± 15.6 years, where 163 (57.4%) were women and 121 (42.6%) were men. Acute urticaria and angioedema occurred together in 149 (52.5%) patients. At least one precipitating factor among the predisposing risk factors was present in 220 (77.5%) patients, and more than one precipitating factor was found in 51 (18%) patients. Medication use was found in 157 (55.3%) patients and infection in 54 (19%). The development of urticaria after food consumption was noted in nine (3.2%) individuals. A history of infection and medication intake was present in 50 (17.6%) patients. A joint history of food consumption and medication intake was present in only one patient. Elevated C-reactive protein level was found in 178 (62.7%) patients and elevated anti-streptolysin O titer in 41 (14.4%) patients. Vitamin B12 deficiency was found in 116 (40.8%) patients and vitamin D deficiency in 254 (89.4%).


Conclusion: Acute urticaria and angioedema may occur as a result of multiple etiological factors, in which different triggers may be present simultaneously.

Abstract 513 | PDF Downloads 431 HTML Downloads 41 XML Downloads 50

References

1. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACı/GA2LEn/EDf/WAo Guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393–414. 10.1111/all.13397

2. Gaig P, Olona M, Muñoz Lejarazu D, Caballero MT, Domínguez FJ, Echechipia S, et al. Epidemiology of urticaria in Spain. J Investig J Investig Allergol Clin Immunol. 2004;14(3):214–20.

3. Ferrer M. Epidemiology, healthcare, resources, use and clinical features of different types of urticaria. J Investig Allergol Clin Immunol. 2009;19(2):21–6.

4. Kulthanan K, Chiawsirikajorn Y, Jiamton S. Acute urticaria: Etiologies, clinical course and quality of life. Asian Pac J Allergy Immunol. 2008;26:1–9.

5. Stevens W, Buchheit K, Cahill KN. Aspirin-exacerbated diseases: Advances in asthma with nasal polyposis, urticaria angioedema, and anaphylaxis. Curr Allergy Asthma Rep. 2015;15:69. 10.1007/s11882-015-0569-2

6. Sánchez-Borges M, Capriles-Hulet, A, Caballero-Fonseca F. Demographic and clinical profiles in patients with acute urticaria. Allergol Immunopathol. 2015;43(4):409–15. 10.1016/j.aller.2014.04.010

7. Köse Ş, Senger SS, Çavdar G. Focal infections accompanying urticaria, a common skin disease. KLIMIK Derg. 2011;24(2):98–100. 10.5152/kd.2011.23

8. Losappio L, Heffler E, Bussolino C, Cannito CD, Carpentiere R, Raie A, et al. Acute urticaria presenting in the emergency room of a general hospital. Eur J Intern Med. 2014;25:147–50. 10.1016/j.ejim.2013.11.003

9. Frigas E, Park MA. Acute urticaria and angioedema: Diagnostic and treatment considerations. Am J Clin Dermatol. 2009;10(4):239–50. 10.2165/00128071-200910040-00004

10. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. The diagnosis and management of acute and chronic urticarial. J Allergy Clin Immunol. 2014;133(5):1270–7. 10.1016/j.jaci.2014.02.036

11. Sabroe RA. Acute urticaria. Immunol Allergy Clin North Am. 2014;34(1):11–21. 10.1016/j.iac.2013.07.010

12. Karadağ AS, Bilgili SG, Calka Ö, Akdeniz N, Özkol HU, Aktar, S. Clinical evaluation of inpatients with acute urticaria. Türkderm Arch Skin Dis Syphilis. 2011;45(4):179–83. 10.4274/turkderm.82653

13. Frigas E, Park MA, Narr BJ, Volcheck GW, Danielson DR, Markus PJ, et al. Preoperative evaluation of patients with history of allergy to penicillin: Comparison of 2 models of practice. Mayo Clin Proc. 2008;83(6):651–57. 10.4065/83.6.651

14. Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J Allergy Clin Immunol. 2015;136:245–51. 10.1016/j.jaci.2015.06.021

15. Dona I, Blanca-Lopez N, Cornejo-Garcia JA, Torres MJ, Laguna JJ, Fernandez J, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: Pattern of response. Clin Exp Allergy. 2011;41(1):86–95. 10.1111/j.1365-2222.2010.03651.x

16. Brennan R, Wazaify M, Shawabkeh H, Boardley I, McVeigh J, Van Hout MC. A scoping review of non-medical and extra-medical use of non-steroidal anti-inflammatory drugs (NSAIDs). Drug Saf. 2021;44:917–28. 10.1007/s40264-021-01085-9

17. Bush K, Bradford PA. β-lactams and β-lactamase inhibitors: An overview. Cold Spring Harb Perspect Med. 2016;6(8):a025247. 10.1101/cshperspect.a025247

18. Minaldi E, Phillips EJ, Norton A. Immediate and delayed hypersensitivity reactions to beta-lactam Antibiotics. Clin Rev Allergy Immunol. 2022 Jun;62(3):449–462. 10.1007/s12016-021-08903-z

19. Solensky R. Hypersensitivity reactions to betalactam antibiotics. Clin Rev Allergy Immunol. 2003;24:201–20. 10.1385/CRIAI:24:3:201

20. Minciullo PL, Cascio A, Barberi G, Sebastiano G. Urticaria and bacterial infections. Allergy Asthma Proc. 2014;35(4):295–302. 10.2500/aap.2014.35.3764

21. Zuberbier T. Urticaria. Allergy. 2003;58:1224–34. 10.1046/j.1398-9995.2003.00327.x

22. Aldehaim AY, Alnegheimish NA, Fathaddin AA. Refractory urticaria with raised antistreptolysin O (ASO) titer: An intriguing case of adult-onset Still’s disease. Am J Case Rep. 2020;21:e927936. 10.12659/AJCR.92793

23. Wheatley C. A scarlet pimpernel for the resolution of inflammation? The role of supra-therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med Hypotheses. 2006;67(1):124–42. 10.1016/j.mehy.2006.01.036

24. Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020;12(7):2097. 10.3390/nu12072097

25. Baeke F, Korf H, Overbergh L, Van Etten E, Verstuyf A, Gysemans C, et al. Human T lymphocytes are direct targets of 1,25-dihydroxy vitamin D3 in the immune system. J Steroid Biochem Mol Biol. 2010;121:221–7. 10.1016/j.jsbmb.2010.03.037

26. Özdemir B, Köksal BT, Karakaş NM, Özbek OY. Serum vitamin D levels decrease in children with acute urticaria. Allergol Immunopathol (Madr). 2016;44(6):512–16. 10.1016/j.aller.2016.04.007

27. Yeşiltepe-Mutlu G, Aksu ED, Bereket A, Hatun Ş. Vitamin D status across age groups in Turkey: Results of 108,742 samples from a single laboratory. J Clin Res Pediatr Endocrinol. 2020;12(3):248–55. 10.4274/jcrpe.galenos.2019.2019.0097